Evidence mapPaperPMID 41903192Full record

ArticleInternational journal of epidemiology2026

Paternal snus use in puberty and increased risk for asthma and allergies in offspring: a RHINE/RHINESSA two-generation study.

Juan Pablo López-Cervantes, Randi J Bertelsen, Vivi Schlünssen, Mathias Holm, Andrei Malinovschi, Lars Modig, Anna Oudin, Francisco Javier Callejas-González, Shyamali C Dharmage, Nils O Jogi and 6 more

Abstract read
In one paragraph

Article in International journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Juan Pablo López-CervantesDepartment of Global Public Health and Primary Care, Centre for International Health, University of Bergen, 5020, Bergen, Norway.ORCID 0000-0002-4668-911X
Randi J BertelsenDepartment of Clinical Science, University of Bergen, 5021, Bergen, Norway.ORCID 0000-0001-5319-525X
Vivi SchlünssenDepartment of Public Health, Research Unit for Environment, Occupation and Health, Danish Ramazzini Centre, Aarhus University, 8000, Aarhus, Denmark.ORCID 0000-0003-4915-1734
Mathias HolmDepartment of Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 41390, Gothenburg, Sweden.ORCID 0000-0002-9327-5139
Andrei MalinovschiDepartment of Medical Sciences: Clinical Physiology, Uppsala University, 751 85, Uppsala, Sweden.ORCID 0000-0002-4098-7765
Lars ModigDepartment of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden.
Anna OudinDepartment of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden.ORCID 0000-0002-9876-0627
Francisco Javier Callejas-GonzálezDepartment of Respiratory Medicine, Albacete University Hospital Complex, 02008, Albacete, Spain.ORCID 0000-0001-8213-5424
Shyamali C DharmageAllergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, VIC 3010, Melbourne, Australia.ORCID 0000-0001-6063-1937
Nils O JogiDepartment of Medical Sciences: Clinical Physiology, Uppsala University, 751 85, Uppsala, Sweden.ORCID 0000-0002-9600-1950
Ane JohannessenDepartment of Global Public Health and Primary Care, University of Bergen, 5020, Bergen, Norway.ORCID 0000-0003-3269-8354
Valentina LandoUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, 37134, Verona, Italy.ORCID 0009-0003-6794-046X
Elin Helga ThorarinsdottirPrimary Care of the Capital Area, Reykjavik, Iceland and Faculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID 0000-0001-6561-3746
Christer JansonDepartment of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, 751 85, Uppsala, Sweden.ORCID 0000-0001-5093-6980
Simone AccordiniUnit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, 37134, Verona, Italy.ORCID 0000-0003-1510-6193
Cecilie SvanesDepartment of Global Public Health and Primary Care, Centre for International Health, University of Bergen, 5020, Bergen, Norway.ORCID 0000-0001-8512-5192

Funding

Asthma and Allergy AssociationBergen Medical Research FoundationERC StG project BRuSH 804199European Union's Horizon 2020 Research and Innovation Program 633212Research Council of Norway 214123Research Council of Norway 228174Research Council of Norway 230827Research Council of Norway 273838Research Council of Norway 274767RHINERHINESSASwedish Asthma and Allergy AssociationSwedish Heart and Lung Association, Vårdal Foundation for Healthcare Science and Allergy ResearchSwedish Heart and Lung FoundationUniversity of BergenUppsala RHINESSAWestern Norwegian Regional Health Authorities 911631Western Norwegian Regional Health Authorities 911892Western Norwegian Regional Health Authorities 912011
6 · The paper itself

Abstract

backgroundEvidence suggests that a father's smoking in puberty may adversely impact respiratory health in offspring, possibly through epigenetic changes in germ cells. This study investigates whether snus use starting in or after puberty influences respiratory health in future offspring.

methodsWe analysed Swedish data from RHINE (Respiratory Health in Northern Europe) parents and RHINESSA (Respiratory Health in Northern Europe, Spain and Australia) offspring by using mixed-effect logistic regression to assess the links between paternal snus initiation around puberty and offspring asthma, chronic bronchitis, rhinitis, and eczema, adjusting for paternal and offspring smoking.

resultsWe identified 1090 offspring-father pairs. The offspring's median age was 29 years (17-51) and 55% were women. The maternal line (n = 1421) was not analysed, as <1% of mothers used snus in puberty. The offspring of fathers starting snus use in puberty (n = 89) had a higher risk of current allergic asthma [odds ratio (OR) 1.42; 95% confidence interval (CI) 1.02-1.97], at least three asthma symptoms with allergy (OR 1.13; 95% CI 1.10-1.21), chronic bronchitis (OR 2.17; 95% CI 1.04-4.54), and eczema (OR 1.45; 95% CI 1.27-1.65). Fathers' snus use starting after puberty (n = 252) showed no consistent associations with offspring outcomes. The effect estimates were consistent after excluding offspring using snus in puberty.

conclusionPaternal snus use starting in puberty was associated with a higher risk of asthma and other respiratory and allergic symptoms in offspring. These findings support the hypothesis that exposures in puberty may impact future generations' respiratory health, possibly through epigenetic changes. This highlights the need for research on exposures during this period and actions to prevent habits that could negatively impact future offspring's health.

Indexed as

AsthmaFathersHypersensitivityPubertySmokingAdolescentAdultBronchitis, ChronicEczemaFemaleHumansLogistic ModelsMaleMiddle AgedRhinitisRisk Factorsasthma and allergiesasthma epidemiologyepigeneticsintergenerationalsurveys and questionnairestobacco

Identifiers

PMID41903192
PMCPMC13032824

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.